Met Life Investment Management, LLC 9 Meters Biopharma, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.6 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$0.85 - $1.33 $72,051 - $112,740
-84,767 Closed
0 $0
Q3 2021

May 17, 2024
BUY
$1.03 - $1.41 $87,310 - $119,521
84,767 New
84,767 $110,000
Q3 2021

Jun 21, 2023
BUY
$1.03 - $1.41 $87,310 - $119,521
84,767 New
84,767 $110,000
Q3 2021

Mar 22, 2023
BUY
$1.03 - $1.41 $87,310 - $119,521
84,767 New
84,767 $110,000
Q3 2021

Nov 15, 2021
BUY
$1.03 - $1.41 $87,310 - $119,521
84,767 New
84,767 $110,000

Others Institutions Holding NMTR

# of Institutions
3
Shares Held
67.9K
Call Options Held
0
Put Options Held
0
View Full List

About 9 METERS BIOPHARMA, INC.

NMTR Quotes by TradingView
  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email